article thumbnail

A Paradigm Shift in Electrophysiology Reimbursement

Vector Remote

What Clinics Can Do to Protect the Diagnosis and Treatment of Cardiac Arrhythmias Scope of Reimbursement Cuts The release of the annual Proposed Medicare Physician Fee Schedule is an event that business leaders and caregivers in healthcare anxiously anticipate.

article thumbnail

PO-06-102 COMPARING ABLATIONS TO ABLATIONS: ARE MANDATED HOSPITAL PRICING LISTS USEFUL FOR COMPARING THE COST OF CARDIAC ABLATION PROCEDURES AT PEER HOSPITALS?

HeartRhythm

As of 2019, the Center for Medicare and Medicaid Services requires that each hospital publish the standard prices of the procedures it offers in a document called a chargemaster. Its effectiveness for comparing scheduled electrophysiology procedures has not been previously described.

article thumbnail

Cardiology in H1 2024

CardiacWire

GLP-1s are for CVD too – So far this year GLP-1s have gone from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming an FDA-approved and Medicare-covered option for CV event reduction. GLP-1s’ cardiovascular impact is likely to continue to expand, given growing evidence that it also improves HF symptoms.

article thumbnail

All About Cardiac Remote Patient Monitoring Software

Vector Remote

All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heart failure, and hypertension requires the ability to monitor a heart’s condition. In response, an increasing number of clinics have chosen to rely on cardiac remote patient monitoring ( RPM ) software.

article thumbnail

2023 Expert Consensus Statement for Remote Device Clinics

Vector Remote

Expert Consensus Statement and Remote Patient Monitoring Guidelines What does the Heart Rhythm Society’s new Expert Consensus Statement say?

article thumbnail

Implementing the 2023 Expert Consensus Statement: A Strategic Roadmap for Device Manufacturer Sales Representatives

Vector Remote

Implementing the 2023 Expert Consensus Statement: A Strategic Roadmap for Device Manufacturer Sales Representatives In the ever-evolving landscape of cardiac device care, keeping pace with guidelines and policies can often seem daunting.

article thumbnail

Comparing complication rates between Abbott Tendril 2088 and competitive manufacturer leads: Novel real‐world data approach

Journal of Cardiovascular Electrophysiology

Methods Medicare fee-for-service (FFS) claims and Abbott device registration databases were linked to identify patients implanted with single-chamber or dual-chamber pacemakers with the Abbott Tendril 2088 lead from January 1, 2014 to December 31, 2019 and were followed through December 31, 2021. Groups were comparable in age (79.78.6